PAM
SCPH

Panagora Asset Management’s scPharmaceuticals SCPH Stock Holding History

Panagora Asset Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-470
Closed -$3K – 2935
2021
Q1 		$3K Buy
+470
New +$3.22K ﹤0.01% 2672
2019
Q2 		– Sell
-16,908
Closed -$51K – 2665
2019
Q1 		$51K Buy
+16,908
New +$58.1K ﹤0.01% 2032

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Panagora Asset Management's SCPH Position: Q2 2021 in Review

Panagora Asset Management sold out of scPharmaceuticals (SCPH) in Q2 2021, closing a stake of 470 shares — an estimated $3K sold.

Panagora Asset Management first reported a position in SCPH in Q1 2019 and held it in 2 quarters. The position peaked at $51K in Q1 2019. 38 funds tracked by Wall St. Rank hold SCPH as of Q2 2021.

  • Panagora Asset Management reported no remaining scPharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Panagora Asset Management sold 470 scPharmaceuticals shares in Q2 2021, an estimated $3K.
  • Panagora Asset Management first reported a position in scPharmaceuticals in Q1 2019 and held it in 2 quarters.
  • Panagora Asset Management's scPharmaceuticals position peaked at $51K in Q1 2019.
  • 38 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.